Table 1. Patients’ characteristics.
Characteristic | Patient data (N = 91) |
Patient age (years; mean±SD) | 66±8 |
Mode of diagnosis | n (%) |
TVP | 13 (14.3%) |
TURP | 36 (39.6%) |
TRUS Biopsy | 36 (39.6% |
Biopsy of distant metastases | n (%) |
Bone biopsy | 2 (2.1%) |
Para-aortic lymph node biopsy | 2 (2.1%) |
Bone marrow biopsy | 1 (1.1%) |
Pelvic mass biopsy | 1 (1.1%) |
Gleason’s score distribution | n (%) |
GS 6 | 3 (3.3%) |
GS 7 | 31 (34.1%) |
GS 8–10 | 55 (60.4%) |
Distant metastases at diagnosis | n (%) |
Yes | 82 (90.1%) |
No | 9 (9.9%) |
PSA at diagnosis, median (range) | 150 (56–626) |